Technetium(I) Complexes of Bathophenanthrolinedisulfonic Acid

Area of Science:

• Radiochemistry
• Nuclear Medicine
• Bioconjugate Chemistry

Background:

• Technetium(I) complexes offer potential for diagnostic imaging due to their favorable properties.
• Bathophenanthrolinedisulfonate (BPS) and imidazole derivatives are versatile ligands for metal complexation.

Purpose of the Study:

• To synthesize and evaluate novel technetium(I) complexes for in vitro and in vivo applications.
• To develop a bone-targeting technetium agent for imaging bone metabolism.
• To explore the potential of isostructural rhenium analogues for optical imaging.

Main Methods:

• Synthesis of technetium(I) complexes with BPS and imidazole ligands.
• Preparation of a bone-targeting analogue using an imidazole-alendronate ligand.
• In vitro stability studies and in vivo biodistribution studies in animal models.
• Synthesis of a luminescent rhenium analogue for fluorescence labeling.

Main Results:

• Technetium(I)-BPS-imidazole complexes were synthesized with high yields.
• [99mTc(CO)3(BPS)(ImAln)]2- showed rapid clearance from non-target tissues and significant skeletal accumulation.
• The bone-targeting agent exhibited prolonged retention in the skeleton (24 hours).
• A rhenium analogue demonstrated luminescent properties for in vitro cell labeling.

Conclusions:

• Technetium(I)-BPS complexes are stable and suitable for radiolabeling.
• The developed bone-targeting agent shows potential for nuclear imaging of bone metabolism.
• Isostructural rhenium complexes can serve as optical probes, enabling dual-modality imaging applications.